Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of OPC-1085EL vs carteolol in primary open-angle glaucoma or ocular hypertension
jRCT2080222438Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Mikeluna in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
Mikeluna
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080222438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222438.